NIH-funded research R01 grant

Understanding how lung fibroblasts drive inflammation after flu infection

Official title: Understanding and targeting fibroblast activation in influenza-triggered lung inflammation and post-viral disease

Funded at University of California Santa Cruz · NIH-11399157 · Data updated 2026-11-12

Researchers aim to understand why some people have long-lasting lung problems after influenza and look for ways to help recovery.

More Influenza research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Santa Cruz
NIH-funded
Lab location1 site (Santa Cruz, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$608,947
NIH project number5R01HL170121-04
Project IDNIH-11399157 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults who have had severe influenza with lung involvement and persistent symptoms after hospital discharge.

Less likely to help

People with minor flu infections or those whose symptoms fully resolve quickly may not benefit from this research.

What this research studies

This project studies why inflammation in the lungs can persist even after the flu virus is cleared and how certain lung fibroblasts may keep fighting the disease. It will examine the cells and signals that keep inflammatory immune cells in the lungs and how this affects repair of the air sacs. By identifying key drivers, the study hopes to point to new approaches to reduce PVLD and improve post-infection recovery. The work involves analyses of human-relevant lung biology and may point toward future therapies to speed return to normal breathing after influenza.

Why it matters

Potential benefit: If successful, the findings could lead to therapies that shorten recovery from severe flu and prevent long-term lung problems.

How similar studies have gone: Preclinical and human-related studies have indicated inflammatory lung fibroblasts can influence disease severity and repair, supporting the rationale for this approach.

Where this research is happening

  • University of California Santa Cruz
    Santa Cruz, United States
    Active

Researchers

  • Principal investigator: Boyd, David Fielding — University of California Santa Cruz
  • Study coordinator: Boyd, David Fielding

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.